초록 ▼

The present invention relates to a rapid and readily reproducible process for stabilizing biologically active substances by combining the biologically active substance witha a stabilizingmixture and drying the resulting mixture into a dry, amorphous product by means of convection drying. The inventi

The present invention relates to a rapid and readily reproducible process for stabilizing biologically active substances by combining the biologically active substance witha a stabilizingmixture and drying the resulting mixture into a dry, amorphous product by means of convection drying. The invention also relates to the amorphous, microscopically homogeneous products which are obtained by this process, are in the form of powders and have a uniform geometric, in particular spherical, shape. The invention furthermore relates to the use of substance mixtures for stabilizing biologically active material, in particular proteins by means of spray drying.

대표청구항 ▼

1. A method of producing dry, amorphous, and stabilized biological material comprising: a) dissolving at least one carbohydrate and at least one amino carboxylic acid into water; b) suspending a biological material into the mixture from step (a); c) adjusting the pH of the solution of step (b)

1. A method of producing dry, amorphous, and stabilized biological material comprising: a) dissolving at least one carbohydrate and at least one amino carboxylic acid into water; b) suspending a biological material into the mixture from step (a); c) adjusting the pH of the solution of step (b) to from about 7.0 to about 8.0; and d) convection drying the solution of step (c) at a temperature from about 100° C. to about 180° C. to a residual moisture content of less than about 8 percent using a method selected from the group consisting of spray-drying, fluidized bed drying, lift air drying and flight drying, thereby producing the dry, amorphous and stabilized biological material having a glass transition temperature of greater than about 20° C. 2. The method of claim 1 wherein the dry, amorphous and stabilized a biological material obtained has a glass transition temperature of greater than about 40° C. and a residual moisture content of less than about 4 percent. 3. The method of claim 1 wherein the dry, amorphous and stabilized biological material obtained are in the form of powders and have particle size range from about 0.0005 mm to about 1.0 mm. 4. The method of claim 3 wherein the dry, amorphous and stabilized biological material obtained are in the form of powders and have particle size range from about 0.001 mm to about 0.1 mm. 5. A method of producing dry, amorphous, and stabilized biological material comprising: a) dissolving at least one amino carboxylic acid into water; b) suspending a biological material into the solution from step (a); c) adjusting the pH of the solution of step (b) to from about 7.0 to about 8.0; and d) convection drying the solution of step (c) at a temperature from about 100° C. to about 180° C. using a method selected from the group consisting of spray-drying, fluidized bed drying, lift air drying and flight drying, thereby producing the dry, amorphous and stabilized biological material with a glass transition temperature of greater than or equal to 20° C. and a residual moisture content of less than about 8 percent. 6. The method of claim 5 wherein the dry, amorphous and stabilized biological material obtained has a glass transition temperature of greater than about 40° C. and a residual moisture content of less than about 4 percent. 7. The method of claim 5 wherein the dry, amorphous and stabilized biological material obtained are in the form of powders and have particle size range from about 0.0005 mm to about 1.0 mm. 8. The method of claim 7 wherein the dry, amorphous and stabilized biological material obtained are in the form of powders and have particle size range from about 0.001 mm to about 0.1 mm.